
MRNA vs ARGX
$MRNA vs $ARGX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MRNA vs ARGX: the quick read
- ·ARGX is the larger company by market cap ($61.96B vs $61.50B).
- ·MRNA has been more active on our scanner (337 vs 36 alerts in 30 days).
- ·ARGX has the smaller float (61.9M vs 354.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·MRNA trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·MRNA draws far more of our scanner's attention, 337 unusual-volume alerts in 30 days against 36, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both are trading in the upper quarter of their 52-week range, so neither is a pullback candidate right now.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MRNA and ARGX on TheDesperateTrader.
- Is MRNA or ARGX the better stock?
- "Better" depends on your goal, and these two are not alike. ARGX is the larger company by market cap ($61.96B vs $61.50B). MRNA has been more active on our scanner (337 vs 36 alerts in 30 days). ARGX has the smaller float (61.9M vs 354.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MRNA and ARGX?
- The differences that matter: they are not in the same business - MRNA is biological products, (no diagnostic substances) and ARGX is biological products, (no diagnostic substances); they are similar in size ($61.50B vs $61.96B); they trade at very different share prices ($153.87 vs $990.32); MRNA sits at 85% of its 52-week range against 80% for ARGX; our scanner flagged MRNA 337 times in the last 30 days against 36 for ARGX. Everything above is measured from the latest completed session and SEC filings.
- Which of MRNA and ARGX is more active right now?
- Right now MRNA is at about 0.8x its normal volume and ARGX is at about 0.9x, so ARGX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MRNA or ARGX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MRNA and ARGX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.